178 related articles for article (PubMed ID: 32422686)
1. Does very early timing of lymph node surgery after resection of the primary tumour improve the clinical outcome of patients with melanoma?
Gambichler T; Bünnemann H; Scheel CH; Bechara FG; Stücker M; Stockfleth E; Becker JC
Clin Exp Dermatol; 2020 Dec; 45(8):1011-1018. PubMed ID: 32422686
[TBL] [Abstract][Full Text] [Related]
2. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.
Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S
Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245
[TBL] [Abstract][Full Text] [Related]
3. Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma.
de Vries M; Hoekstra HJ; Hoekstra-Weebers JE
Ann Surg Oncol; 2009 Oct; 16(10):2840-7. PubMed ID: 19639366
[TBL] [Abstract][Full Text] [Related]
4. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
Huang K; Misra S; Lemini R; Chen Y; Speicher LL; Dawson NL; Tolaymat LM; Bagaria SP; Gabriel EM
J Surg Oncol; 2020 Nov; 122(6):1057-1065. PubMed ID: 32654173
[TBL] [Abstract][Full Text] [Related]
5. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck.
Fritsch VA; Cunningham JE; Lentsch EJ
Otolaryngol Head Neck Surg; 2016 Jan; 154(1):94-103. PubMed ID: 26399717
[TBL] [Abstract][Full Text] [Related]
6. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
[TBL] [Abstract][Full Text] [Related]
7. Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma.
Oude Ophuis CM; van Akkooi AC; Rutkowski P; Powell WE; Robert C; Testori A; van Leeuwen BL; Siegel P; Eggermont AM; Verhoef C; Grünhagen DJ
Br J Surg; 2017 May; 104(6):726-733. PubMed ID: 28218385
[TBL] [Abstract][Full Text] [Related]
8. Does the time interval between sentinel lymph node biopsy and completion lymph node dissection affect outcome in malignant melanoma? A retrospective cohort study.
Richtig G; Richtig E; Neiss AN; Quehenberger F; Gmainer DG; Kamolz LP; Lumenta DB
Int J Surg; 2020 Mar; 75():160-164. PubMed ID: 32036082
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
[TBL] [Abstract][Full Text] [Related]
10. Twelve years' experience of sentinel lymph node biopsy for melanoma at a rural New Zealand hospital.
Sakowska MM; Smith N; Coutts RJ
N Z Med J; 2014 Jun; 127(1395):12-22. PubMed ID: 24929689
[TBL] [Abstract][Full Text] [Related]
11. Is there a relation between type of primary melanoma treatment and the development of intralymphatic metastasis? A review of the literature.
Sloot S; Speijers MJ; Bastiaannet E; Hoekstra HJ
Cancer Treat Rev; 2016 Apr; 45():120-8. PubMed ID: 27015564
[TBL] [Abstract][Full Text] [Related]
12. Management of regional lymph nodes in the elderly melanoma patient: patient selection, accuracy and prognostic implications.
Grotz TE; Puig CA; Perkins S; Ballman K; Hieken TJ
Eur J Surg Oncol; 2015 Jan; 41(1):157-64. PubMed ID: 25468751
[TBL] [Abstract][Full Text] [Related]
13. Investigation of prognostic factors for non-sentinel lymph node metastasis in patients undergoing sentinel lymph node biopsy for cutaneous malignant melanoma: Experience from a reference centre in Turkey.
Yalcin CE; Melenkis S; Demir L; Okur FT; Sagir MS; Ercan A
J Plast Reconstr Aesthet Surg; 2024 Apr; 91():167-172. PubMed ID: 38417393
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients.
Howman-Giles R; Shaw HM; Scolyer RA; Murali R; Wilmott J; McCarthy SW; Uren RF; Thompson JF
Ann Surg Oncol; 2010 Jan; 17(1):138-43. PubMed ID: 19672660
[TBL] [Abstract][Full Text] [Related]
15. [Research progress of sentinel lymph node biopsy and regional dissection in melanoma].
Liu WF; Yang FJ; Niu XH
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):481-485. PubMed ID: 31357833
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node micrometastasis may predict non-sentinel involvement in cutaneous melanoma patients.
Glumac N; Hocevar M; Zadnik V; Snoj M
J Surg Oncol; 2008 Jul; 98(1):46-8. PubMed ID: 18452214
[TBL] [Abstract][Full Text] [Related]
17. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States.
Bilimoria KY; Balch CM; Bentrem DJ; Talamonti MS; Ko CY; Lange JR; Winchester DP; Wayne JD
Ann Surg Oncol; 2008 Jun; 15(6):1566-76. PubMed ID: 18414952
[TBL] [Abstract][Full Text] [Related]
18. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
Guggenheim MM; Hug U; Jung FJ; Rousson V; Aust MC; Calcagni M; Künzi W; Giovanoli P
Ann Surg; 2008 Apr; 247(4):687-93. PubMed ID: 18362633
[TBL] [Abstract][Full Text] [Related]
19. Does Stage Migration Occur as a Consequence of Omitting Completion Lymph Node Dissection for Melanoma?
Senders ZJ; Bartlett EK; Mouw TJ; McMasters KM; Egger ME
Ann Surg Oncol; 2023 Jun; 30(6):3648-3654. PubMed ID: 36934378
[TBL] [Abstract][Full Text] [Related]
20. Recurrence factors in patients with cutaneous melanoma and positive sentinel lymph node treated in a single reference unit in Buenos Aires.
Nardi WS; Toffolo Pasquini M; Tomé F; Vigovich F; Cora MF; Quildrian SD
Medicina (B Aires); 2024; 84(2):279-288. PubMed ID: 38683513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
